Meanwhile, combination immunotherapy strategies for HCC can induce antitumor immunity by activating the cyclic guanosine monophosphate–adenosine monophosphate (GMP-AMP) synthase (cGAS)/stimulator of interferon genes (STING) signaling pathway [25, 26]. Here, STING1 is linked to hepatocellular carcinoma.